| Classification | n | % |
| Total | 1373 | 100% |
| TST negative | 408 | 29.7% |
| TST positive | 965 | 70.3% |
| No LTBI | 529 | 54.8% |
| TST under 15 mm | 355 | 67.1% |
| TST ≥ 15 mm | 174 | 32.9% |
| LTBI | 436 | 45.2% |
| No IPT administered, LTFU | 114 | 26.1% |
| IPT administered† | 322 | 73.9% |
| Completed IPT | 284 | 88.2% |
| Discontinued by patient | 5 | 1.6% |
| Discontinued due to side effects | 33 | 10.2% |
| AST and/or ALT over 200 IU/L | 26 | 78.8% |
| Nausea and pruritis | 7 | 21.2% |